Condition: PIK3CA-Related Overgrowth Spectrum (PROS) · PIK3CA-related Vascular Malformations (PRVM) · Sponsor: Haihe Biopharma Co., Ltd.
This study is a multi-center, open-label, single arm, phase I/II study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of CYH33 in patients with PIK3CA-related overgrowth spectrum (PROS) and PIK3CA-related vascular malformations (PRVM)
This description comes directly from the study's public registry record.
Xiaoxi Lin, MD · +86-13701997136 · linxiaoxi@126.com
Always discuss trial participation with your own doctor first.
| Capital Center for Children's Health, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| Plastic Surgery Hospital, Chinese Academy of Medical Sciences | Beijing, Beijing Municipality, China | Recruiting |
| Fujian Medical University Union Hospital | Fuzhou, Fujian, China | Recruiting |
| Guangzhou Women and Children's Medical Center | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Henan Provincial People's Hospital | Zhengzhou, Henan, China | Recruiting |
| The Second Xiangya Hospital of Central South University | Changsha, Hunan, China | Recruiting |
| Shanghai Ninth People Hospital, Shanghai Jiaotong University School of Medicine | Shanghai, Shanghai Municipality, China | Recruiting |
| West China Hospital of Sichuan University | Chengdu, Sichuan, China | Recruiting |
| Tonan Hospital | Sapporo, Hokkaido, Japan | Recruiting |
| National Hospital Organization Kobe Medical Center | Kobe, Hyōgo, Japan | Recruiting |
| Yokohama City University Hospital | Yokohama, Kanagawa, Japan | Recruiting |
| Tohoku University Hospital | Sendai, Miyagi, Japan | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06975618